Skip to main content
Premium Trial:

Request an Annual Quote

University of Iowa Lands $600K Bioinformatics Grant

NEW YORK (GenomeWeb News) – The University of Iowa has won a nearly $600,000 grant from the National Institutes of Health to start a program for doctoral students that will provide bioinformatics training for life sciences and biomedical applications, according to the university.

The five-year grant will enable students from 22 different doctoral disciplines to receive an interdisciplinary certificate in a program offering a core of bioinformatics coursework and seminars, as well as advice from mentors on a variety of bioscience and informatics topics.

The goal of the program, called "Bioinformatics Training in the Life Sciences and Biomedicine," is to provide graduates in life sciences modern computational methods and skills for solving biomedical problems. Students in the program will work with researchers from various colleges and with scientists at the UI Center for Bioinformatics and Computational Biology (CBCB) to study the molecular and genetic basis of a variety of diseases.

"No field has been impacted more by advances in micro-chip manufacturing processes, high-performance computing and advanced networking technology than bio-medicine and the basic life sciences over the past two decades," Tom Casavant, professor of electrical/computer and biomedical engineering and director of the CBCB, said in a statement.

"This new graduate program answers the need for formal training for students by emphasizing both bioscience and informatics, while developing the skills to effectively apply these quantitative methods in novel ways to problems such as human genetic disease diagnosis and treatment," he added.

"[S]tudents will encounter didactic training, but also work with cooperating thesis advisors from different fields to develop a coherent research program that spans the two disciplines. Very few programs exist that function in this decentralized and intentionally interdisciplinary manner," he said.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.